185 results on '"Bibas, Michele"'
Search Results
2. Plasmablastic Lymphoma
3. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy
4. Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
5. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
6. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients
7. Venous thromboembolism in people living with HIV infection (PWH)
8. PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
9. Publisher Correction: Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition
10. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition
11. Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
12. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
13. The biology and treatment of plasmablastic lymphoma
14. Free Light Chains and the Risk of Nonmalignant AIDS Events in HIV-Infected Patients Treated With Combination Antiretroviral Therapy
15. Impact of Direct-Acting Antivirals on the Outcome of HIV/HCV Coinfected Patients with Non-Hodgkin Lymphomas in the Modern Anti-Retroviral Therapy Era: A Retrospective Multicenter Study of 74 Cases
16. HIV infection as a permanent, acquired risk factor for VTE
17. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection
18. Prognostic Factors for Advanced-Stage Human Immunodeficiency Virus-Associated Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Combined Antiretroviral Therapy: A Multi-Institutional Retrospective Study
19. The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review
20. Immunogenicity and safety of BNT162b2 COVID‐19 vaccine in a chronic lymphocytic leukaemia patient
21. Bleeding and Coagulopathies in Critical Care
22. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
23. Elevated P-Selectin in Severe Covid-19: Considerations for therapeutic options
24. Pulmonary Disease Due to Kayexalate Aspiration
25. Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy
26. Polyclonal serum-free light chains elevation in HIV-infected patients
27. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkinʼs lymphoma and its correlation with antiretroviral therapy
28. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study
29. Immune Landscape in Burkitt Lymphoma reveals M2-macrophage polarization and Correlation between PD-L1 expression and Non-Canonical EBV latency program
30. Early-Stage Hodgkinʼs Lymphoma
31. Osteonecrosis of the Jaw in Patients with Multiple Myeloma Treated with Bisphosphonates: Definition and Management of the Risk Related to Zoledronic Acid
32. Pulmonary Disease Due to Kayexalate Aspiration
33. Chronic Idiopathic Thrombocytopenic Purpura
34. High Serum Gamma-Glutamyltransferase Concentrations In A Family
35. Hepatitis C Virus And Cryoglobulinemia
36. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
37. Waldenstrom Macroglobulinemia
38. Plasmablastic Lymphoma
39. Bone Marrow CD34+Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines
40. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
41. Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis
42. Bone Marrow CD34+ Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines.
43. CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
44. Chronic HIV-Infected Patients Show an Impaired Dendritic Cells Differentiation of Bone Marrow CD34+ Cells
45. Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases
46. Polyclonal Serum Free Light Chains: A Biomarker of Disease Prognosis or of Immune Senescence?
47. HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study
48. HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
49. Leishman-Donovan bodies in the bone marrow biopsy
50. HIV-associated plasmablastic lymphoma diagnosed by fine-needle aspiration cytology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.